140 related articles for article (PubMed ID: 29381084)
21. Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.
Sheng SL; Wang Q; Huang G; Yu B; Qin WX
J Clin Lab Anal; 2009; 23(3):179-85. PubMed ID: 19455631
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.
Jingting J; Changping W; Ning X; yibei Z; Jun W; Mei J; Bin X; Peter NE; Xueguan Z
J Clin Lab Anal; 2009; 23(4):213-8. PubMed ID: 19623644
[TBL] [Abstract][Full Text] [Related]
23. Clinical application of serum alpha-fetoprotein-IgM complexes on the diagnosis of primary hepatocellular carcinoma in Kazakh and Han populations.
Wu J; Zou H; Jiang JT; Li XD; Zhao XM; Jar K; Wang H; Xu B; Wu CP
Tumori; 2013; 99(4):535-9. PubMed ID: 24326844
[TBL] [Abstract][Full Text] [Related]
24. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.
Yang T; Xing H; Wang G; Wang N; Liu M; Yan C; Li H; Wei L; Li S; Fan Z; Shi M; Chen W; Cai S; Pawlik TM; Soh A; Beshiri A; Lau WY; Wu M; Zheng Y; Shen F
Clin Chem; 2019 Dec; 65(12):1543-1553. PubMed ID: 31672853
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
[TBL] [Abstract][Full Text] [Related]
26. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
27. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
Nguyen MH; Garcia RT; Simpson PW; Wright TL; Keeffe EB
Hepatology; 2002 Aug; 36(2):410-7. PubMed ID: 12143050
[TBL] [Abstract][Full Text] [Related]
28. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
Teofănescu I; Gologan E; Stefănescu G; Bălan G
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):39-46. PubMed ID: 20509274
[TBL] [Abstract][Full Text] [Related]
29. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
30. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
[TBL] [Abstract][Full Text] [Related]
31. Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.
Trerotoli P; Fransvea E; Angelotti U; Antonaci G; Lupo L; Mazzocca A; Mangia A; Antonaci S; Giannelli G
Mol Cancer; 2009 May; 8():29. PubMed ID: 19473531
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Jirun P; Zhang G; Kim HK; Ha SA; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Yoo J; Kim S; Park YG; Wang J; Yang Y; Xu Z; Huang Z; Lee YK; Song EY; Kim JW
Dis Markers; 2011; 30(6):307-15. PubMed ID: 21725159
[TBL] [Abstract][Full Text] [Related]
33. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
34. Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis.
Biasiolo A; Chemello L; Quarta S; Cavalletto L; Bortolotti F; Caberlotto C; Beneduce L; Bernardinello E; Tono N; Fassina G; Gatta A; Pontisso P
J Viral Hepat; 2008 Apr; 15(4):246-9. PubMed ID: 18248333
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
36. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
[TBL] [Abstract][Full Text] [Related]
37. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
[No Abstract] [Full Text] [Related]
38. Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
Comunale MA; Wang M; Rodemich-Betesh L; Hafner J; Lamontagne A; Klein A; Marrero J; Di Bisceglie AM; Gish R; Block T; Mehta A
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1222-9. PubMed ID: 21467232
[TBL] [Abstract][Full Text] [Related]
39. Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
Beneduce L; Castaldi F; Marino M; Tono N; Gatta A; Pontisso P; Fassina G
Int J Biol Markers; 2004; 19(2):155-9. PubMed ID: 15255549
[TBL] [Abstract][Full Text] [Related]
40. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
